Orthofix Medical Inc. 8-K

What Happened

• Orthofix Medical Inc. (OFIX) filed Form 8-K on May 5, 2026 to announce its financial results for the quarter ended March 31, 2026. The company furnished a press release reporting those results (Exhibit 99.1) and an investor relations presentation (Exhibit 99.2). The report was signed by CFO Julie Andrews.

Key Details

• Press release announcing Q1 2026 results furnished as Exhibit 99.1 (dated May 5, 2026).
• Corporate investor relations presentation furnished as Exhibit 99.2 (dated May 5, 2026); the company says it may use this presentation, in whole or in part and with possible modifications, in presentations to investors, analysts and others during the fiscal year ending December 31, 2026 (Reg FD disclosure).
• The 8-K was filed under Item 2.02 (Results of Operations and Financial Condition) and Item 7.01 (Regulation FD Disclosure); exhibits include the press release and presentation.

Why It Matters

• This filing provides the company’s most recent quarterly earnings disclosure (quarterly results, revenue and other financial metrics will be in the attached press release). Investors should review the press release and investor presentation to see reported revenue, earnings (or loss), cash flow, any updated outlook or commentary from management, and any changes in business trends disclosed for Q1 2026. The Reg FD notice indicates the presentation may be used broadly in investor communications during 2026, so look for these materials or related investor events for additional context.